{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:37:51Z","timestamp":1792442271490,"version":"4.5.0"},"reference-count":97,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007372","name":"Association Belge contre les Maladies Neuro-Musculaires","doi-asserted-by":"publisher","award":["2018"],"award-info":[{"award-number":["2018"]}],"id":[{"id":"10.13039\/100007372","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014255","name":"Fonds de dotation CSL Behring pour la recherche","doi-asserted-by":"publisher","award":["2020"],"award-info":[{"award-number":["2020"]}],"id":[{"id":"10.13039\/501100014255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Muscle atrophy is an active process controlled by specific transcriptional programs, in which muscle mass is lost by increased protein degradation and\/or decreased protein synthesis. This review explores the involvement of Toll-like receptors (TLRs) in the muscle atrophy as it is observed in muscular dystrophies, disorders characterized by successive bouts of muscle fiber degeneration and regeneration in an attempt to repair contraction-induced damage. TLRs are defense receptors that detect infection and recognize self-molecules released from damaged cells. In muscular dystrophies, these receptors become over-active, and are firmly involved in the sustained chronic inflammation exhibited by the muscle tissue, via their induction of pro-inflammatory cytokine expression. Taming the exaggerated activation of TLR2\/4 and TLR7\/8\/9, and their downstream effectors in particular, comes forward as a therapeutic strategy with potential to slow down disease progression.<\/jats:p>","DOI":"10.3390\/ijms21124440","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T06:11:02Z","timestamp":1592892662000},"page":"4440","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Progressive Skeletal Muscle Atrophy in Muscular Dystrophies: A Role for Toll-Like Receptor-Signaling in Disease Pathogenesis"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9403-4401","authenticated-orcid":false,"given":"Boel","family":"De Paepe","sequence":"first","affiliation":[{"name":"Neuromuscular Reference Center, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/med.21279","article-title":"Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers","volume":"5","author":"Mosquiera","year":"2013","journal-title":"Med. Res. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/mus.21624","article-title":"Muscle weakness and atrophy are associated with decreased regenerative capacity and changes in MTOR signaling in skeletal muscle of vednerable (18-24-month-old) dystrophic mdx mice","volume":"41","author":"Mouisel","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"438675","DOI":"10.1155\/2014\/438675","article-title":"From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: The role of lymphocytes","volume":"2014","author":"Madaro","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_6","first-page":"891972","article-title":"Sytemic inflammation in Duchenne muscular dystrophy: Association with muscle function and nutritional status","volume":"2015","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: A constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"FASEB J."},{"key":"ref_8","first-page":"917","article-title":"Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: Potential for attenuation of myofiber necrosis","volume":"46","author":"Creus","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ajime, T.T., Serr\u00e9, J., W\u00fcst, R.C.I., Messa, G.A.M., Poff\u00e9, C., Swaminathan, A., Maes, K., Janssens, W., Troosters, T., and Degens, H. (2020). Two weeks smoking cessation reverses cigarette smoke-induced skeletal muscle atrophy and mitochondrial dysfunction in mice. Nicotine Tob. Res.","DOI":"10.1093\/ntr\/ntaa016"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1111\/febs.12253","article-title":"Mechanisms regulating skeletal muscle growth and athrophy","volume":"280","author":"Schiaffino","year":"2013","journal-title":"FEBS J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis. Models Mech."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.biochi.2019.07.014","article-title":"Skeletal muscle atrogenes: From rodent models to human pathologies","volume":"166","author":"Taillandier","year":"2019","journal-title":"Biochimie"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1535370217749494","article-title":"Myogenic regulatory factors: The orchestrators of myogenesis after 30 years of discovery","volume":"243","author":"Asfour","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1621","DOI":"10.12688\/f1000research.19139.1","article-title":"Mitochondrial dysregulation and muscle disuse atrophy","volume":"8","author":"Li","year":"2019","journal-title":"F1000 Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"De Paepe, B. (2019). The changed transcriptome of muscular dystrophy and inflammatory myopathy: Contributions of non-coding RNAs to muscle damage and recovery. OBM Genet., 3.","DOI":"10.21926\/obm.genet.1902079"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Chen, M., Lian, D., Li, Y., Li, Y., Wang, J., Deng, S., Yu, K., and Zhengxing, L. (2019). Non-coding RNA regulates the myogenesis of skeletal muscle satellite cells, injury repair and diseases. Cells, 8.","DOI":"10.3390\/cells8090988"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Brusa, R., Magri, F., Bresolin, N., Comi, G.P., and Corti, S. (2020). Noncoding RNAs in Duchenne and Becker muscular dystrophies: Role in pathogenesis and future prognostic and therapeutic perspectives. Cell Mol. Life Sci.","DOI":"10.1007\/s00018-020-03537-4"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12199-014-0405-7","article-title":"Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy","volume":"19","author":"Matsuzaka","year":"2014","journal-title":"Environ. Health Prev. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/embor.2010.208","article-title":"miR-31 modulates dystrophin expression: New implications for Duchenne muscular dystrophy therapy","volume":"12","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.3389\/fneur.2020.00304","article-title":"Longitudinal study of three microRNAs in Duchenne muscular dystrophy and Becker muscular dystrophy","volume":"11","author":"Trifunov","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/MCB.01394-14","article-title":"Novel long noncoding RNAs (lncRNAs) in myogenesis: A MiR-31 overlapping lncRNA transcript controls myoblast differentiation","volume":"35","author":"Ballarino","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201100133","article-title":"miRNAs as serum biomarkers for Duchenne muscular dystrophy","volume":"3","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0002-9440(10)63523-7","article-title":"Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins","volume":"163","author":"Bonuccelli","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Saenz, A., Azpitarte, M., Armananzas, R., Leturcq, F., Alzualde, A., Inza, I., Garc\u00eda-Bragado, F., De la Herran, G., Corcuera, J., and Cabello, A. (2008). Gene expression profiling in limb girdle muscular dystrophy 2A. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003750"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/nan.12034","article-title":"Muscle atrophy in limb girdle muscular dystrophy 2A: A morphometric and molecular study","volume":"39","author":"Fanin","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/mus.24167","article-title":"Muscle atrophy, ubiquitin-proteasome, and autophagic pathways in dysferlinopathy","volume":"50","author":"Fanin","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jmb.2005.09.068","article-title":"Trim 32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin","volume":"354","author":"Kudryashova","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1038\/cddis.2012.159","article-title":"Autophagy as a new therapeutic target in Duchenne muscular dystrophy","volume":"3","author":"Morisi","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1242\/jcs.114041","article-title":"Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies","volume":"126","author":"Sandri","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1357-2725(99)00095-3","article-title":"Calpains and muscular dystrophies","volume":"32","author":"Tidball","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnen\/60.3.302","article-title":"Caspase 3 expression correlates with skeletal muscle apoptosis in duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment?","volume":"60","author":"Sandri","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00314217","article-title":"Muscle hypertrophy in Duchenne muscular dystrophy","volume":"236","author":"Cros","year":"1989","journal-title":"J. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nmd.2014.01.015","article-title":"Quantitative MRI and strenght measurements in the assessment of muscle quality in Duchenne muscular dystrophy","volume":"24","author":"Wokke","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Henry, C.C., Martin, K.S., Ward, B.B., Handsfield, G.G., Pierce, S.M., and Blemker, S.S. (2017). Spatial and age-related changes in the microstructure of dystrophic and healthy diaphragms. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183853"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ajpath.2013.07.013","article-title":"Sparing of the dystrophin-deficient cranial Sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs","volume":"183","author":"Nghiem","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jcsm.12491","article-title":"Serum amyloid A1 mediates myotube atrophy via Toll-like receptors","volume":"11","author":"Hahn","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ono, Y., and Sakamoto, K. (2017). Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-\u03baB signaling pathway and myoblast-derived tumor necrosis factor-\u03b1. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0182040"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Langhans, C., Weber-Carstens, S., Schmidt, F., Hamati, J., Kny, M., Zhu, X., Wollersheim, T., Koch, S., Krebs, M., and Schultz, H. (2014). Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092048"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.exger.2018.02.002","article-title":"Repetitive TLR-3 activation in the lung induces skeletal muscle adaptations and cachexia","volume":"106","author":"Graber","year":"2018","journal-title":"Exp. Gerontol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41374-018-0081-0","article-title":"Attenuation of ventilation-induced diaphragm dysfunction through Toll-like receptor 4 and nuclear factor-\u03baB in a murine endotoxemia model","volume":"98","author":"Li","year":"2018","journal-title":"Lab. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"R503","DOI":"10.1152\/ajpregu.00330.2019","article-title":"Pharmacological inhibition of TLR4 ameliorates muscle and liver ceramide content after disuse in previously physically active mice","volume":"318","author":"McKenzie","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.20220","article-title":"Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids","volume":"50","author":"Ulfgren","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cyto.2010.02.021","article-title":"HMGB1, a potent proinflammatory cytokine in sepsis","volume":"51","author":"Huang","year":"2010","journal-title":"Cytokine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2016.10.009","article-title":"TLR4-HMGB1 signaling pathway affects the inflammatory reaction of autoimmune myositis by regulating MHC-I","volume":"41","author":"Wan","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1016\/j.healun.2013.01.631","article-title":"Anti-IL6R attenuates humoral responses to allograft in a mouse model of allosensitization","volume":"32","author":"Wu","year":"2013","journal-title":"J. Heart Lung Transplant."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.3389\/fimmu.2019.00482","article-title":"TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection","volume":"10","author":"Henrick","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1128\/IAI.00286-06","article-title":"Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-\u03baB and calcineurin","volume":"74","author":"Boyd","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/path.4689","article-title":"Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy","volume":"239","author":"Mojumdar","year":"2016","journal-title":"J. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e00184-19","DOI":"10.1128\/MCB.00184-19","article-title":"The toll-like receptor\/myd88\/xbp1 signaling axis mediates skeletal muscle wasting during cancer cachexia","volume":"39","author":"Bohnert","year":"2019","journal-title":"Mol. Cell. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"C542","DOI":"10.1152\/ajpcell.00192.2009","article-title":"p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting","volume":"298","author":"McClung","year":"2010","journal-title":"Am. J. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1096\/fj.10-164152","article-title":"Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways","volume":"25","author":"Doyle","year":"2011","journal-title":"FASEB J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0014-5793(03)00505-2","article-title":"Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection","volume":"544","author":"Dehoux","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jcb.21060","article-title":"Curcumin prevents lipopolysaccharide-induced atrogin-1\/MAFbx upregulation and muscle mass loss","volume":"100","author":"Jin","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/jmf.2016.3759","article-title":"Leucine protects against skeletal muscle atrophy in lipopolysaccharide-challenged rats","volume":"20","author":"Wan","year":"2017","journal-title":"J. Med. Food"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e13255","DOI":"10.14814\/phy2.13255","article-title":"TLR4-defective (C3H\/HeJ) mice are not protected from cast immobilization-induced muscle atrophy","volume":"5","author":"Kawanishi","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sin, T.K., Zhang, G., Zhang, Z., Gao, S., Li, M., and Li, Y.P. (2019). Cancer takes a toll on skeletal muscle by releasing heat shock proteins\u2014An emerging mechanism of cancer-induced cachexia. Cancers, 11.","DOI":"10.3390\/cancers11091272"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature07405","article-title":"The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor","volume":"456","author":"Ewald","year":"2008","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","article-title":"Mitochondrial ROS signaling in organismal homeostasis","volume":"163","author":"Shadel","year":"2015","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/JIR.S232009","article-title":"Mitochondrial dynamic dysfunction as a main triggering factor for inflammation associated chronic non-communicable diseases","volume":"13","author":"Geto","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1073\/pnas.1417108112","article-title":"Mitochondrial alarmins released by degenerating motor axon terminals activate perisynaptic Schwann cells","volume":"112","author":"Duregotti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature10992","article-title":"Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure","volume":"485","author":"Oka","year":"2012","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e96553","DOI":"10.15252\/embj.201796553","article-title":"Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency","volume":"37","author":"Noguera","year":"2018","journal-title":"EMBO J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-020-1992-7","article-title":"TLR9 and beclin 1 crosstalk regulates muscle AMPK activation in exercise","volume":"578","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"ref_65","first-page":"184","article-title":"The role of fibrosis in Duchenne muscular dystrophy","volume":"31","author":"Klingler","year":"2012","journal-title":"Acta Myol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1681\/ASN.2015080923","article-title":"Toll-like receptors 2 and 4 are potential therapeutic targets in peritoneal dialysis-associated fibrosis","volume":"28","author":"Raby","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathways","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1189\/jlb.2A0913-487R","article-title":"The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4","volume":"96","author":"Verstak","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri2038","article-title":"Cooperation of Toll-like receptor signals in innate immune defence","volume":"7","author":"Trinchieri","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature01182","article-title":"Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4","volume":"420","author":"Yamamoto","year":"2002","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000086657","article-title":"TLR signaling and the function of dendritic cells","volume":"86","author":"Hemmi","year":"2005","journal-title":"Chem. Immunol. Allergy"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-Like Receptor Signaling Pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/19491034.2018.1471947","article-title":"Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies","volume":"9","author":"Cappelletti","year":"2018","journal-title":"Nucleus"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2353\/ajpath.2010.090058","article-title":"Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle","volume":"176","author":"Rawat","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/hmg\/ddu735","article-title":"Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy","volume":"24","author":"Giordano","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGF\u03b2 in Duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2011","journal-title":"Semin. Immunopathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/hmg\/ddt656","article-title":"Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle","volume":"23","author":"Yu","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1093\/hmg\/ddy258","article-title":"MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice","volume":"27","author":"Gallot","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4207","article-title":"The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A\/J mice: Role of endogeneous TLR ligands","volume":"231","author":"Uaesoontrachoon","year":"2013","journal-title":"J. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1158\/0008-5472.CAN-17-3878","article-title":"The TLR7\/8\/9 Antagonist IMO-8503 inhibits cancer-induced cachexia","volume":"78","author":"Calore","year":"2018","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1093\/nar\/gkt078","article-title":"Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9","volume":"41","author":"Kandimalla","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nmd.2011.11.007","article-title":"N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis","volume":"22","author":"Terrill","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e7015","DOI":"10.1113\/JP275232","article-title":"Antioxidant therapy in a mouse model of Duchenne muscular dystrophy: Some promising results but with a weighty caveat","volume":"595","author":"Head","year":"2017","journal-title":"J. Physiol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Burns, D.P., Drummond, S.E., Bolger, D., Coiscaud, A., Murphy, K.H., Edge, D., and O\u2019Halloran, K.D. (2019). N-acetylcysteine decreases fibrosis and increases force-generating capacity of mdx diaphragm. Antioxidants, 8.","DOI":"10.3390\/antiox8120581"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1113\/JP274229","article-title":"Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy","volume":"595","author":"Pinniger","year":"2017","journal-title":"J. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2008.02.003","article-title":"Why have antioxidants failed in clinical trials?","volume":"101","author":"Steinhubl","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.fsi.2016.03.148","article-title":"Protective effects of leucine against lipopolysaccharide-induced inflammatory response in Labeo rohita fingerlings","volume":"52","author":"Giri","year":"2016","journal-title":"Fish Shellfish Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mus.880070704","article-title":"Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine","volume":"7","author":"Mendell","year":"1984","journal-title":"Muscle Nerve"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2249.2007.03571.x","article-title":"Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat","volume":"151","author":"Kessel","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mok, E., Letellier, G., Cuisset, J.M., Denjean, A., Gottrand, F., Alberti, C., and Hankard, R. (2009). Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: A randomized crossover trial. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005448"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e2434","DOI":"10.3389\/fimmu.2018.02434","article-title":"Pharmacological inhibition of Toll-like receptor-4 signaling by TAK242 prevents and induces regression of experimental organ fibrosis","volume":"9","author":"Bhattacharyya","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Park, M.H., and Hong, J.T. (2016). Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches. Cells, 5.","DOI":"10.3390\/cells5020015"},{"key":"ref_96","first-page":"670","article-title":"The effect of specific IKK\u03b2 inhibitors on the cytosolic expression of I\u03baB-\u03b1 and the nuclear expression of p65 in dystrophic (MDX) muscle","volume":"7","author":"Carlson","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2119\/molmed.2012.00299","article-title":"Adeno-associated virus serotype 8 (AAV8) delivery of recombinant A20 to skeletal muscle reduces pathological activation of nuclear factor (NF)-kappaB in muscle of mdx mice","volume":"18","author":"Charan","year":"2013","journal-title":"Mol. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4440\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:41:15Z","timestamp":1760175675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/12\/4440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":97,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["ijms21124440"],"URL":"https:\/\/doi.org\/10.3390\/ijms21124440","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]}}}